Repair of DNA interstrand crosslinks: Molecular mechanisms and clinical relevance

Lancet Oncology

Volumn 2, Issue 8, 2001, Pages 483-490

  McHugh, Peter J ^a   Spanswick, Victoria J ^a   Hartley, John A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ANIMAL; DNA REPAIR; DRUG EFFECT; FANCONI ANEMIA; GENETICS; HUMAN; MAMMAL; NEOPLASM; REVIEW;

ANIMALS; DNA REPAIR; DNA, NEOPLASM; FANCONI ANEMIA; HUMANS; MAMMALS; NEOPLASMS;

EID: 0035436539     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(01)00454-5     Document Type: Review

References (59)

1. O'Connor P.M., Kohn K.W. Comparative pharmacokinetics of DNA lesion formation and removal following treatment of L1210 cells with nitrogen mustards. Cancer Commun. 2:1990;387-394.
2. Hartley J.A., Souhami R.L., Berardini M.D. Electrophoretic and chromatographic separation methods used to reveal interstrand crosslinking of nucleic acids. J Chromatogr. 618:1993;277-288.
3. Kohn K.W., Ewig R.A., Erickson L.C., Zwelling L.A. Friedberg E.C., Hanawalt P.C. DNA repair. A laboratory manual of research procedures. 1981;379 Marcel Dekker, New York.
4. Hartley J.M., Spanswick V.J., Gander M., et al. Measurement of DNA crosslinking in patients on ifosfamide therapy using the single cell gel electrophoresis (comet) assay. Clin Cancer Res. 5:1999;507-512.
5. Spanswick V.J., Hartley J.M., Ward T.H., Hartley J.A. Measurement of drug-induced DNA interstrand crosslinking using the single cell gel electrophoresis (comet) assay. Brown R., Boger-Brown U. Methods in molecular medicine, Vol 28: Cytotoxic drug resistance mechanisms. 1999;143-154 Humana Press, New Jersey.
6. Rudd G.N., Hartley J.A., Souhami R.L. Persistence of cisplatin-induced DNA interstrand crosslinking in peripheral blood mononuclear cells from elderly and young individuals. Cancer Chemother Pharmacol. 35:1995;323-326.
7. Torres-Garcia S.J., Cousineau L., Caplan S., Panasci L. Correlation of resistance to nitrogen mustards in chronic lymphocytic leukemia with enhanced removal of melphalan-induced DNA crosslinks. Biochem Pharmacol. 38:1989;3122-3123.
8. Spanswick V.J., Craddock C., Sekhar M., Hartley J.A. Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma. Br J Cancer. 1:(Suppl):2000;16.
9. Friedberg E.C., Walker G.C., Siede W. DNA repair and mutagenesis. 1995;American Society for Microbiology, Washington, DC.
10. Cleaver J.E., Kramer K.H. Xeroderma pigmentosum and Cockayne syndrome. Scriver, et al. The metabolic and molecular basis of inherited disease. 1995;4393-4419 MacGraw-Hill, New York.
11. Batty D.P., Wood R.D. Damage recognition in nucleotide excision repair of DNA. Gene. 241:2000;193-204.
12. Evans E., Moggs J.G., Hwang J.R., Egly J.-M., Wood R.D. Mechanism of open complex and dual incision formation by human nucleotide excision repair factors. EMBO J. 16:1997;6559-6573.
13. nd phosphodiester bond 59 and the 6 phosphodiester bond 39 to the photodimer. Proc Natl Acad Sci USA. 89:1992;3664-3668.
14. Sancar A. DNA excision repair. Annu Rev Biochem. 65:1996;43-81.
15. Friedberg E.C. Relationships between DNA repair and transcription. Annu Rev Biochem. 65:1996;15-42.
16. Balajee A.S., Bohr V.A. Genomic heterogeneity of nucleotide excision repair. Gene. 250:2000;15-30.
17. Koberle B., Masters J.R., Hartley J.A., Wood R.D. Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours. Curr Biol. 9:1999;273-276.
18. Cox M.M., Goodman M.F., Kreuzer K.N., et al. The importance of repairing stalled replication forks. Nature. 404:2000;37-41.
19. Richardson C., Jasin M. Coupled homologous and nonhomologous repair of a double-strand breaks preserves genomic integrity in mammalian cells. Mol Cell Biol. 23:2000;9068-9075.
20. Paques F., Haber J.E. Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae. Microb Mol Biol Rev. 63:1999;349-404.
21. Haber J.E. Lucky breaks: analysis of recombination in saccharomyces. Mutat Res. 451:2000;53-69.
22. Sargent R.G., Meservy J.L., Perkins B.D., et al. Role of nucleotide excision repair gene ERCC1 in formation of recombination-dependent rearrangements in mammalian cells. Nucleic Acids Res. 28:2000;3771-3778.
23. Critchlow S.E., Jackson S.P. DNA end-joining: from yeast to man. Trends Biochem Sci. 23:1998;394-398.
24. Cole R.S. Repair of DNA containing interstrand crosslinks in Escherchia coli: sequential excision and recombination. Proc Natl Acad Sci USA. 70:1973;1064-1068.
25. Van Houten B., Gamper H., Holbrook S.R., Hearst J.E., Sancar A. Action mechanism of ABC excision nuclease on a DNA substrate containing a psoralen crosslink at a defined position. Proc Natl Acad Sci USA. 83:1986;8077-8081.
26. Cheng S., Sancar A., Hearst J.E. RecA-dependent incision of psoralen-crosslinked DNA by (A)BC excinuclease. Nucleic Acids Res. 19:1991;657-663.
27. Jachymczyk W.J., von Borstel R.C., Mowat M.R., Hastings P.J. Repair of interstrand crosslinks in DNA of Saccharomyces cerevisiae requires two systems for DNA repair: the RAD3 system and the RAD51 system. Mol Gen Genet. 182:1981;196-205.
28. Miller R.D., Prakash L., Prakash S. Genetic control of excision of Saccharomyces cerevisiae interstrand crosslinks inducedby psoralen plus near-UV light. Mol Cell Biol. 2:1982;939-948.
29. Dalhardon M., Averbeck D. Pulsed field electrophoresis of the repair of psoralen plus UVA induced DNA photoproducts in Saccharomyces cerevisiae. Mutat Res. 336:1995;49-60.
30. McHugh P.J., Sones W.R., Hartley J.A. Repair of intermediate structures produced at DNA interstrand crosslinks in Saccharomyces cerevisiae. Mol Cell Biol. 20:2000;3425-3433.
31. Berardini M., Mackay W., Loechler E.L. A site-specific study of a plasmid containing a single nitrogen mustard crosslink: evidence for a second, recombination-independent pathway for the DNA repair of interstrand crosslinks. Biochemistry. 36:1997;303-313.
32. Berardini M., Foster P.L., Loechler E.L. DNA polymerase II (polB) is involved in a new DNA repair pathway for DNA interstrand crosslinks in Escherichia coli. J Bacteriol. 181:1999;2878-2882.
33. Damia G., Imperatori L., Stefanini M., D'Incalci M. Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents. Int J Cancer. 66:1996;779-783.
34. De Silva I.U., McHugh P.J., Clingen P.H., Hartley J.A. Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand crosslinks in mammalian cells. Mol Cell Biol. 20:2000;7980-7990.
35. Hoy C.A., Thompson L.H., Mooney C.L., Salazar E.P. Defective DNA crosslink removal in Chinese hamster cell mutants hypersensitive to bifunctional alkylating agents. Cancer Res. 45:1985;1737-1743.
36. Kaye J., Smith C.A., Hanawalt P.C. DNA repair in human cells containing photoadducts of 8-methoxypsoralen or angelicin. Cancer Res. 40:1980;696-702.
37. Vuksanovic L., Cleaver J.E. Unique crosslink and monoadduct repair characteristics of a xeroderma pigmentosum revertant cell line. Mutat Res. 184:1987;255-263.
38. Mu D., Bessho T., Nechev L.V., et al. DNA interstrand crosslinks induce futile repair synthesis in mammalian cell extracts. Mol Cell Biol. 20:2000;2446-2454.
39. Kuraoka I., Kobertz W.R., Ariza R.R., Biggestaff M., Essigmann J.M., Wood R.D. Repair of an interstrand DNA crosslink initiated by ERCC1-XPF repair/recombination nuclease. J Biol Chem. 275:2000;26632-26636.
40. Bessho T., Mu D., Sancar A. Initiation of DNA interstrand crosslink repair in humans: the nucleotide excision repair system makes dual incisions 59 to the crosslinked base and removes a 22-to-28-nucelotide long damage-free strand. Mol Cell Biol. 17:1997;6822-6830.
41. Akkari Y.M., Bateman R.L., Reifsteck C.A., Olson S.B., Grompe M. DNA replication is required to elicit cellular responses to psoralen-induced DNA interstrand crosslinks. Mol Cell Biol. 20:2000;8283-8289.
42. Li L., Peterson C.A., Lu X., Wei P., Legerski R.J. Interstrand crosslinks induce DNA synthesis in damaged and undamaged plasmids in mammalian cell extracts. Mol Cell Biol. 19:1999;30-56.
43. Li L., Peterson C.A., Zhang X., Legerski R.J. Requirement for PCNA and RPA in interstrand crosslink-induced DNA synthesis. Nucleic Acids Res. 28:2000;1424-1427.
44. Morrison C., Takeda S. Genetic analysis of homologous recombination in vetebrate somatic cells. Int J Biochem Cell Biol. 32:2000;817-831.
45. Takata M., Sasaki M.S., Sonoda E., et al. The Rad51 paralog Rad51B promotes homologous recombinational repair. Mol Cell Biol. 20:2000;6476-6482.
46. Essers J., Hendriks R.W., Swagemakers S.M., et al. Disruption of mouse RAD54 reduces ionizing radiation resistance and homologous recombination. Cell. 89:1997;195-204.
47. Husain A., He G., Venkatraman E.S., Spriggs D.R. BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II). Cancer Res. 58:1998;1120-1123.
48. Bhattacharyya A., Ear U.S., Koller B.H., Weichselbaum R.R., Bishop D.K. The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA crosslinking agent cisplatin. J Biol Chem. 275:2000;23899-23903.
49. Wang X., Peterson C.A., Zheng H., Nairn R.S., Legerski R.J., Li L. Involvement of nucleotide excision repair in a recombination-independent and error-prone pathway of DNA interstrand crosslink repair. Mol Cell Biol. 21:2001;713-720.
50. Duckworth-Rysiecki G., Taylor A.M.R. Effects of ionising radiation on cells from Fanconi's anemia patients. Cancer Res. 45:1985;416.
51. D' Andrea A.D., Grompe M. Molecular Biology of Fanconi anemia: implications for diagnosis and therapy. Blood. 90:1997;1725-1736.
52. Timmers C., Taniguchi T., Hejna J., et al. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell. 7:2001;241-248.
53. de Winter J.P., van Der Weel L., De Groot J., et al. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum Mol Genet. 9:2000;2665-2674.
54. Garcia-Higuera I., Taniguchi T., Ganasan S., et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell. 7:2001;249-262.
55. Thurston D.E. Nucleic acid targeting: therapeutic strategies for the 21st century. Br J Cancer. 80:(suppl 1):1999;65-85.
56. Springer C.J., Niculescu-Duvaz I. Antibody-directed enzyme prodrug therapy (ADEPT): a review. Adv Drug Deliv Rev. 26:1997;151-172.
57. Connors T.A. The choice of prodrugs for gene directed enzyme prodrug therapy of cancer. Gene Ther. 2:1995;702-709.
58. Hartley JA, Brooks N, McHugh PJ, et al., SJG-136 (NSC-D694501)-A novel DNA sequence specific minor groove crosslinking agent with significant antitumour activity. Proc Am Assoc Cancer Res 2000; 41: Abs 2703.
59. Gregson S.J., Howard P.W., Hartley J.A., et al. Design, synthesis and evaluation of a novel pyrrolobenzodiazepine DNA-interactive agent with highly efficient crosslinking ability and potent cytotoxicity. J Med Chem. 44:2001;737-748.